Spurred by rise in deals, experts say ADC innovation is set to advance
At the Swiss Biotech Day conference, experts discussed how the development of antibody drug conjugates (ADCs) may evolve in the near future.
At the Swiss Biotech Day conference, experts discussed how the development of antibody drug conjugates (ADCs) may evolve in the near future.
For the process, the researchers employed a machine learning method called transfer learning.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
TetraScience and Google Cloud link for AI-driven drug developments
Bayer and Google Cloud to develop AI solutions for radiologists
Q&A: BARDA wants to back tech that can combat multiple infections, says director
Can pharma overcome generative AI’s bias problem?